Chennai, Aug. 29 -- Highlights:

* A new strategy for treating prostate cancer patients has been developed

* It involves inhibition of a specific cellular protein called CDK7 using drug //molecules

* These new CDK7 inhibitors will be a boon for prostate cancer patients with advanced-stage cancer

Prostate cancer could soon be treated using a new therapeutic strategy that involves blocking a specific protein known as CDK7 (cyclin-dependent kinase 7), which kills metastatic prostate cancer cells that are resistant to standard therapies.

The new study was conducted at the Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.

The study, published in Cancer Discovery, was led by Dr. Irfan A. Asangani, PhD, who is an As...